Prevalence of oral HPV infection in cervical HPV positive women and their sexual partners

  • T. K. Eggersmann
  • K. Sharaf
  • P. Baumeister
  • C. Thaler
  • C. J. Dannecker
  • U. Jeschke
  • S. Mahner
  • K. Weyerstahl
  • T. Weyerstahl
  • F. Bergauer
  • J. K. S. GallwasEmail author
Gynecologic Oncology



Human papillomavirus (HPV) infection represents the primary cause of anogenital premalignant and malignant disease. Regarding the high prevalence of cervical HPV infection and the increasing incidence of HPV associated oropharyngeal cancer in recent years, a significant viral transmission from the cervical to the oral site, possibly depending on the sexual behavior must be considered. The present study aims to determine the prevalence of oral HPV infection in cervical HPV positive and negative women and their sexual partners.


Cervical HPV positive and negative women and their sexual partners took part in the study. Cervical smears, oral smears and mouthwashes were taken from women attending gynecological outpatient clinics in two different institutions. Further, oral smears as well as mouthwashes of their sexual partners were obtained whenever possible. HPV genotyping was performed using the Cobas® polymerase chain reaction and nucleic acid hybridization assay for the detection of 14 high-risk HPV types. In addition, all participants were invited to complete a personal questionnaire.


144 HPV positive and 77 HPV negative women and altogether 157 sexual partners took part in the study. Age, sexual behaviour, medication, smoking and alcohol consumption were distributed equally in both groups. Cervical HPV positive women had a significantly higher number of sexual partners. One woman with a HPV positive cervical smear and one partner of a woman with a HPV positive cervical smear showed an oral HPV infection. No oral HPV infections were detected in the HPV negative control group. The overall incidence of oral HPV infection was 0.5%, the incidence of oral HPV infection in women with a positive cervical smear was 0.7%.


The data demonstrate that the overall risk of an oral HPV infection is low. HPV transmission to the oropharynx by autoinoculation or oral-genital contact constitute a rare and unlikely event.


HPV Cervical carcinoma Oropharyngeal carcinoma OSCC Sexually transmitted disease 


Author contributions

TKE, TW, KW, CJD. SM and JKSG protocol/project development. TKE, TW, KW, KS, PB,FB and JKSG data collection and management, data analysis. TW, FB and CJT cytopathologic evaluation. KW, TKE and JKSG manuscript writing/editing. TKE, SM, CJT, UJ, CJD and JKSG: protocol/project development, data analysis. UJ, JKSG: statistical analysis. All authors interpreted the results and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

Authors JKSG and CJD declare that they have received speaker honoraria from companies MSD and Roche. Author SM declares that he has received speaker honoraria from Astra Zeneca, Novartis, MSD, Roche, Clovis, Teva, Tesaro and Sensor Kinesis. SK, PB, CJT, UJ, KW, FB and TW declare no conflicts of interests. There was no financial support of this study. Authors TKE and JKSG state that they have full control of all primary data and that they agree to allow the Journal to review their data if requested.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study has been approved by the Institutional Review Board of the University of Munich (Number: 645-16). Informed consent was obtained from all patients.


  1. 1.
    Bernard HU (2005) The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol 32(Suppl 1):S1–S6. CrossRefGoogle Scholar
  2. 2.
    Brianti P, De Flammineis E, Mercuri SR (2017) Review of HPV-related diseases and cancers. New Microbiol 40(2):80–85Google Scholar
  3. 3.
    Delere Y, Remschmidt C, Leuschner J, Schuster M, Fesenfeld M, Schneider A et al (2014) Human papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling. BMC Infect Dis 14:87. CrossRefGoogle Scholar
  4. 4.
    Winer RL, Hughes JP, Feng Q, Xi LF, Cherne S, O’Reilly S et al (2011) Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women. Cancer Epidemiol Biomark 20(4):699–707. CrossRefGoogle Scholar
  5. 5.
    Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet (London, England). 370(9590):890–907. CrossRefGoogle Scholar
  6. 6.
    Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19.;2-f CrossRefGoogle Scholar
  7. 7.
    Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S et al (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31(36):4550–4559. CrossRefGoogle Scholar
  8. 8.
    Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V et al (2013) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck 35(5):747–755. CrossRefGoogle Scholar
  9. 9.
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92(9):709–720CrossRefGoogle Scholar
  10. 10.
    Cohen N, Fedewa S, Chen AY (2018) Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. Google Scholar
  11. 11.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301. CrossRefGoogle Scholar
  12. 12.
    Huang SH, O’Sullivan B (2017) Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol 18(7):40. CrossRefGoogle Scholar
  13. 13.
    Fakhry C, D’Souza G (2013) Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol 49(9):863–871. CrossRefGoogle Scholar
  14. 14.
    de Lima Rocha MG, Faria FL, Goncalves L, Souza Mdo C, Fernandes PA, Fernandes AP (2012) Prevalence of DNA-HPV in male sexual partners of HPV-infected women and concordance of viral types in infected couples. PLoS One 7(7):e40988. CrossRefGoogle Scholar
  15. 15.
    Kreimer AR, Alberg AJ, Daniel R, Gravitt PE, Viscidi R, Garrett ES et al (2004) Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189(4):686–698. CrossRefGoogle Scholar
  16. 16.
    Syrjanen S (2007) Human papillomaviruses in head and neck carcinomas. N Engl J Med 356(19):1993–1995. CrossRefGoogle Scholar
  17. 17.
    Ramqvist T, Dalianis T (2010) Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis 16(11):1671–1677. CrossRefGoogle Scholar
  18. 18.
    Psyrri A, Gouveris P, Vermorken JB (2009) Human papillomavirus-related head and neck tumors: clinical and research implication. Curr Opin Oncol 21(3):201–205CrossRefGoogle Scholar
  19. 19.
    Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ (2006) Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 31(4):259–266. CrossRefGoogle Scholar
  20. 20.
    Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L et al (2012) Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 307(7):693–703. CrossRefGoogle Scholar
  21. 21.
    Kellokoski J, Syrjanen S, Yliskoski M, Syrjanen K (1992) Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol Immunol 7(1):19–23CrossRefGoogle Scholar
  22. 22.
    Meyer MF, Huebbers CU, Siefer OG, Vent J, Engbert I, Eslick GD et al (2014) Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection. Oral Oncol 50(1):27–31. CrossRefGoogle Scholar
  23. 23.
    Castro TP, Bussoloti Filho I (2006) Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol. 72(2):272–282CrossRefGoogle Scholar
  24. 24.
    Badaracco G, Venuti A, Di Lonardo A, Scambia G, Mozzetti S, Benedetti Panici P et al (1998) Concurrent HPV infection in oral and genital mucosa. J Oral Pathol Med 27(3):130–134CrossRefGoogle Scholar
  25. 25.
    Uken RB, Brummer O, von Schubert-Bayer C, Brodegger T, Teudt IU (2016) Oral HPV prevalence in women positive for cervical HPV infection and their sexual partners: a German screening study. Eur Arch Otorhinolaryngol 273(7):1933–1942. CrossRefGoogle Scholar
  26. 26.
    Woelber L, Breuer J, Meyer T, Vettorazzi E, Prieske K, Bohlmann I et al (2017) Oral human papillomavirus in women with high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis 21(3):177–183. CrossRefGoogle Scholar
  27. 27.
    Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Michael Berry J et al (2013) HIV-associated disruption of mucosal epithelium facilitates paracellular penetration by human papillomavirus. Virology 446(1–2):378–388. CrossRefGoogle Scholar
  28. 28.
    Lydiatt WM, Patel SG, O’Sullivan B, Brandwein, Ridge JA, Migliacci JC et al (2017) Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin 67(2):122–137. CrossRefGoogle Scholar
  29. 29.
    Rieth KKS, Gill SR, Lott-Limbach AA, Merkley MA, Botero N, Allen PD et al (2018) Prevalence of high-risk human papillomavirus in tonsil tissue in healthy adults and colocalization in biofilm of tonsillar crypts. JAMA Otolaryngol Head Neck Surg 144(3):231–237. CrossRefGoogle Scholar
  30. 30.
    Combes JD, Dalstein V, Gheit T, Clifford GM, Tommasino M, Clavel C et al (2017) Prevalence of human papillomavirus in tonsil brushings and gargles in cancer-free patients: the SPLIT study. Oral Oncol 66:52–57. CrossRefGoogle Scholar
  31. 31.
    Franceschi S, Combes JD, Dalstein V, Caudroy S, Clifford G, Gheit T et al (2015) Deep brush-based cytology in tonsils resected for benign diseases. Int J Cancer 137(12):2994–2999. CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • T. K. Eggersmann
    • 1
  • K. Sharaf
    • 2
  • P. Baumeister
    • 2
  • C. Thaler
    • 1
  • C. J. Dannecker
    • 1
  • U. Jeschke
    • 1
  • S. Mahner
    • 1
  • K. Weyerstahl
    • 3
  • T. Weyerstahl
    • 4
  • F. Bergauer
    • 4
  • J. K. S. Gallwas
    • 1
    • 5
    Email author
  1. 1.Department of Obstetrics and Gynecology and Breast CenterUniversity of MunichMunichGermany
  2. 2.Department of Otorhinolaryngology, Head and Neck SurgeryUniversity of MunichMunichGermany
  3. 3.Faculty of Medicine/DentistryDanube Private UniversityKremsAustria
  4. 4.Amedes Medizinisches VersorgungszentrumMunichGermany
  5. 5.Department of Obstetrics and GynecologyUniversity of MunichMunichGermany

Personalised recommendations